German Anguiano Torres (@gerantomd) 's Twitter Profile
German Anguiano Torres

@gerantomd

Medico Internista, Cardiológo Clínico, Master en Teoría Cardiovascular, FSIAC. Los comentarios vertidos aquí son a título propio

ID: 122515304

calendar_today13-03-2010 00:15:05

3,3K Tweet

384 Followers

1,1K Following

NEJM (@nejm) 's Twitter Profile Photo

Presented at #AHA25: In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT

Presented at #AHA25:

In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT
NEJM (@nejm) 's Twitter Profile Photo

Presented at #AHA25: In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:

Presented at #AHA25: 

In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

META‑AF – Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation #METAAF #AHA25 🫀can metformin ⤵️ AF after ablation? 🫀excluded those with DM 🫀all received lifestyle counseling 🫀 disproportionately male 👎🏽 🫀weight loss in both groups about the same

META‑AF – Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation #METAAF #AHA25 
🫀can metformin ⤵️ AF after ablation?
🫀excluded those with DM
🫀all received lifestyle counseling 
🫀 disproportionately male 👎🏽
🫀weight loss in both groups about the same
MIЯVΛƬ #IC (@mirvatalasnag) 's Twitter Profile Photo

#AHA25 in the world of AF a lot of science was presented: 1) #OCEAN Rivaroxaban did not signif ↓ incidence of stroke, systemic embolism or new embolic stroke vs ASA among high risk patients for stroke post ablation 1-year prior NEJM nejm.org/doi/full/10.10… 2) #ADAPT_AF

#AHA25 in the world of AF a lot of science was presented:

1) #OCEAN
Rivaroxaban did not signif ↓ incidence of stroke, systemic embolism or new embolic stroke vs ASA among high risk patients for stroke post ablation 1-year prior

<a href="/NEJM/">NEJM</a> 
nejm.org/doi/full/10.10…

2) #ADAPT_AF
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

☕️ #AHA25 #DECAFTrial #DECAF Can eliminating coffee prevent AF recurrence? In DECAF, ~200 post-cardioversion pts were randomized to coffee abstinence vs continued coffee ☕️Conflicting data about coffee effect on arrhythmia: RCT of 200 pts s/p cardioversion of AF ☕️76% male 👎🏽 ☕️

☕️ #AHA25 #DECAFTrial #DECAF
Can eliminating coffee prevent AF recurrence?

In DECAF, ~200 post-cardioversion pts were randomized to coffee abstinence vs continued coffee
☕️Conflicting data about coffee effect on arrhythmia: RCT of 200 pts s/p cardioversion of AF
☕️76% male 👎🏽
☕️
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

From JAMA: Adding coronary CT angiography to traditional risk scores modestly improved prediction of first coronary events in a large population-based study. #AHA25 AHA Science ja.ma/4hOC2o3

From <a href="/JAMA_current/">JAMA</a>: Adding coronary CT angiography to traditional risk scores modestly improved prediction of first coronary events in a large population-based study. 

#AHA25 <a href="/AHAScience/">AHA Science</a> 

ja.ma/4hOC2o3
Almudena Castro Conde (@almucastro01) 's Twitter Profile Photo

#LaSECteLleva a ver los vídeos resumen de los estudios más importantes presentados en #AHA25 ( día 1 y 2): 🎥 Vesalius ✅ 🎥Coral-reef lípidos ✅ 🎥BB >50% PostIAM mta ❌ 🎥 Closure-AF ❌ 🎥 OCEAN ❌ 🎥 DAPA-EAT ✅ 🎥SOTA-Cardia ✅ 🎥DECAF ✅ 🎥DAPA-Dare ❌ 🎥Subestudios MAPLE

#LaSECteLleva a ver los vídeos resumen de los estudios más importantes presentados en #AHA25 ( día 1 y 2):

🎥 Vesalius ✅
🎥Coral-reef lípidos ✅
🎥BB &gt;50% PostIAM mta ❌
🎥 Closure-AF ❌
🎥 OCEAN ❌
🎥 DAPA-EAT ✅
🎥SOTA-Cardia ✅
🎥DECAF ✅
🎥DAPA-Dare ❌
🎥Subestudios MAPLE
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

SURPASS-CVOT trial: Tirzepatide was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: clinicaltrialresults.org/wp-content/upl…

SURPASS-CVOT trial: Tirzepatide was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: clinicaltrialresults.org/wp-content/upl…
Dr. Filippo Cademartiri (@fcademartiri) 's Twitter Profile Photo

❤️‍🔥 AHA 2025 – Nonobstructive Coronary Artery Disease (NOCA): Time to Act! Slipczuk et al., Circulation 2025 🇺🇸 Non obstructive CAD is the modern frontier of atherosclerosis prevention, management, treatment. And Cardiac CT is the epicenter of this paradigm shift. 🎯 What’s new:

❤️‍🔥 AHA 2025 – Nonobstructive Coronary Artery Disease (NOCA): Time to Act!
Slipczuk et al., Circulation 2025 🇺🇸

Non obstructive CAD is the modern frontier of atherosclerosis prevention, management, treatment. And Cardiac CT is the epicenter of this paradigm shift.

🎯 What’s new:
SEIC - Sociedad Española de Imagen Cardíaca (@imagencardiaca) 's Twitter Profile Photo

Aplicaciones clínicas de la ecocardiografía de deformación miocárdica: Declaración de consenso clínico ASE/EACVI-ESC 👓 buff.ly/DfDoPeK ◀️ Primera publicación de la nueva sección "García Fernandez te pone al día"... ¡No te lo pierdas!

Aplicaciones clínicas de la ecocardiografía de deformación miocárdica: Declaración de consenso clínico ASE/EACVI-ESC
👓 buff.ly/DfDoPeK ◀️
Primera publicación de la nueva sección "García Fernandez te pone al día"...
¡No te lo pierdas!
Dr. Filippo Cademartiri (@fcademartiri) 's Twitter Profile Photo

🚀 Calcium Score & CCTA: Key Highlights from the 2025 AHA Scientific Statement (DOI: 10.1161/CIR.0000000000001394) Non-obstructive CAD in Chest Pain Patients 🧊 1. CAC = Atherosclerotic Burden, Not Just a Number CAC is one of the strongest predictors of future ASCVD risk—better

🚀 Calcium Score &amp; CCTA: Key Highlights from the 2025 AHA Scientific Statement (DOI: 10.1161/CIR.0000000000001394)

Non-obstructive CAD in Chest Pain Patients

🧊 1. CAC = Atherosclerotic Burden, Not Just a Number
CAC is one of the strongest predictors of future ASCVD risk—better
NEJM (@nejm) 's Twitter Profile Photo

Beta-blocker use after myocardial infarction reduces the risk of death in patients with a reduced ejection fraction, but its benefit is less clear in patients without a reduced ejection fraction. Research findings from the REBOOT trial are summarized in a new Quick Take video.

Beta-blocker use after myocardial infarction reduces the risk of death in patients with a reduced ejection fraction, but its benefit is less clear in patients without a reduced ejection fraction. Research findings from the REBOOT trial are summarized in a new Quick Take video.
Oscar Arias (@oacerebro) 's Twitter Profile Photo

Guía básica para leer una revisión sistemática + metaanálisis y aplicar los resultados a los pacientes. Una guía obligada para los profesionales de la salud. repositorio.uchile.cl/bitstream/hand…

Guía básica para leer una revisión sistemática + metaanálisis y aplicar los resultados a los pacientes.

Una guía obligada para los profesionales de la salud. 

repositorio.uchile.cl/bitstream/hand…
NEJM (@nejm) 's Twitter Profile Photo

In older patients with frailty who were receiving antihypertensive drugs and had a systolic blood pressure below 130 mm Hg, reducing antihypertensive drugs did not lead to lower all-cause mortality over 4 years than usual care. Full RETREAT-FRAIL trial results and Research

In older patients with frailty who were receiving antihypertensive drugs and had a systolic blood pressure below 130 mm Hg, reducing antihypertensive drugs did not lead to lower all-cause mortality over 4 years than usual care. Full RETREAT-FRAIL trial results and Research
European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

#EHJCVI 🫀 Curious about the differences in diastolic dysfunction guidelines across societies? 📖 This editorial by @jgrapsa, Edgar Argulian, Otto Smiseth unpacks key differences and their clinical impact 👉 Read more: ow.ly/PhOx50XwIa9 #EchoFirst #CVImaging #Echocardiography

#EHJCVI 🫀 Curious about the differences in diastolic dysfunction guidelines across societies? 📖 This editorial by @jgrapsa, <a href="/argulian/">Edgar Argulian</a>, <a href="/OttoSmiseth/">Otto Smiseth</a> unpacks key differences and their clinical impact 👉 Read more: ow.ly/PhOx50XwIa9 

#EchoFirst #CVImaging #Echocardiography